Royal DSM and Evonik, as part of their 50-50 joint venture, have opened a commercial-scale US$200 million facility in Nebraska, USA, to make omega-3 fatty acids from natural marine algae for sustainable salmon farming. 

I am pleased that together with Evonik we have reached a key milestone in turning the tide: through Veramaris, we are able to reduce the aquaculture industry’s reliance on the world’s finite fish oil resources for these vital omega-3 fatty acids,’ said Feike Sijbesma, CEO and chairman of DSM. ‘This fits perfectly with our purpose-led performance driven strategy, focused on addressing the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all our stakeholders.'

This story uses material from DSM, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.